Sysmex Corporation Stock

Equities

6869

JP3351100007

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-23 am EDT 5-day change 1st Jan Change
2,488 JPY +1.53% Intraday chart for Sysmex Corporation +0.79% -5.01%
Sales 2024 * 453B 2.93B Sales 2025 * 493B 3.19B Capitalization 1,528B 9.87B
Net income 2024 * 52.21B 337M Net income 2025 * 59.82B 386M EV / Sales 2024 * 3.26 x
Net cash position 2024 * 50.73B 328M Net cash position 2025 * 60B 388M EV / Sales 2025 * 2.98 x
P/E ratio 2024 *
29.4 x
P/E ratio 2025 *
27 x
Employees 9,500
Yield 2024 *
1.14%
Yield 2025 *
1.12%
Free-Float 74.2%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.53%
1 week+0.79%
Current month-6.52%
1 month-8.19%
3 months-11.11%
6 months+6.74%
Current year-5.01%
More quotes
1 week
2 305.00
Extreme 2305
2 497.50
1 month
2 305.00
Extreme 2305
2 796.67
Current year
2 305.00
Extreme 2305
2 856.33
1 year
2 236.00
Extreme 2236
3 480.00
3 years
2 236.00
Extreme 2236
5 241.67
5 years
1 938.00
Extreme 1938
5 241.67
10 years
1 040.00
Extreme 1040
5 241.67
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 86-08-31
President 65 87-07-31
Chief Tech/Sci/R&D Officer 59 00-05-31
Members of the board TitleAgeSince
Chief Executive Officer 74 86-08-31
Director/Board Member 67 20-05-31
President 65 87-07-31
More insiders
Date Price Change Volume
24-04-23 2,488 +1.53% 1 486 200
24-04-22 2,450 +5.53% 2,041,000
24-04-19 2,322 -5.24% 2,440,400
24-04-18 2,450 +0.43% 1,118,300
24-04-17 2,440 -1.15% 1,577,900

Delayed Quote Japan Exchange, April 23, 2024 at 02:00 am EDT

More quotes
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,450 JPY
Average target price
3,050 JPY
Spread / Average Target
+24.48%
Consensus